journal article·2008-08

Towards control of smooth muscle cell differentiation in synthetic 3D scaffolds

Simon C. Baker, Jennifer Southgate

Biomaterials· Volume 29· Issue 23
Publisher page

Abstract

A central tenant of tissue engineering is that cells should be able to recapitulate full functional tissue capability when placed within an appropriate architecture or scaffold. The aim of this study was to examine the effect of three-dimensional (3D) architecture on the differentiated phenotype of human smooth muscle cells derived from the stroma of the lower urinary tract. Stromal cell cultures were established from surgical specimens and the differentiated smooth muscle cell phenotype was monitored by gene expression, immunofluorescence and immunoblotting. Expression of contractile proteins, including smooth muscle myosin and smoothelin, was lost by cultures grown on two-dimensional (2D) tissue culture polystyrene, but was regained to some extent by the removal of serum and by the addition of TGFbeta1. Stromal cells were seeded onto plasma-coated electrospun polystyrene scaffolds to examine the influence of 3D architecture on smooth muscle cell phenotype, but differentiation was inhibited by serum proteins that adsorbed non-specifically onto the large surface area of the scaffold. Stromal cells failed to adhere to the scaffold in serum-free conditions, but laminin pre-coating of the scaffold prevented serum adsorption and promoted cell attachment and differentiation. The study highlights how non-specific factors, such as serum adsorption, may confound the development of materials for tissue engineering.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Bone Tissue Engineering Materials · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (38)

Show source-provided references
1. Influence of the physical properties of two-dimensional polyester substrates on the growth of normal human urothelial and urinary smooth muscle cells in vitro10.1016/j.biomaterials.2007.01.032 ↗
2. Characterisation of electrospun polystyrene scaffolds for three-dimensional in vitro biological studies10.1016/j.biomaterials.2006.01.026 ↗
3. Bladder tissue engineering
4. Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5′ and first intron promoter regions10.1161/01.RES.84.7.852 ↗
5. Evolutionarily conserved promoter region containing CArG∗-like elements is crucial for smooth muscle myosin heavy chain gene expression10.1161/01.RES.82.5.566 ↗
6. The smooth muscle myosin heavy chain gene exhibits smooth muscle subtype-selective modular regulation in vivo10.1074/jbc.M105402200 ↗
7. Contribution of serum response factor and myocardin to transcriptional regulation of smoothelins10.1016/j.cardiores.2005.12.018 ↗
8. Aortic carboxypeptidase-like protein, a novel protein with discoidin and carboxypeptidase-like domains, is up-regulated during vascular smooth muscle cell differentiation10.1074/jbc.273.25.15654 ↗
9. Aortic carboxypeptidase-like protein is regulated by transforming growth factor beta in 3T3-L1 preadipocytes10.1016/j.yexcr.2005.04.031 ↗
10. Transdifferentiation of preadipose cells into smooth muscle-like cells: role of aortic carboxypeptidase-like protein10.1016/j.yexcr.2003.10.020 ↗
11. A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues10.1177/42.8.8027531 ↗
12. Detection of immune system cells in paraffin wax-embedded ovine tissues10.1053/jcpa.2001.0475 ↗
13. In vitro assessment of decelularised porcine dermis as a matrix for urinary tract reconstruction10.1111/j.1464-410X.2004.05047.x ↗
14. Transforming growth factor-beta 1 and ascorbate regulate proliferation of cultured smooth muscle cells by independent mechanisms10.1016/S0021-9150(98)00102-6 ↗
15. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase10.1074/jbc.273.44.28860 ↗
16. Acrylic acid grafting and collagen immobilization on poly(ethylene terephthalate) surfaces for adherence and growth of human bladder smooth muscle cells10.1016/S0142-9612(02)00061-3 ↗
17. Regulation of differentiation and growth of normal adult and neoplastic epithelia by inductive mesenchyme
18. Adsorption of BSA on highly carboxylated microspheres – quantitative effects of surface functional groups and interaction forces10.1006/jcis.1996.0075 ↗
19. Argon plasma treatment of polystyrene microtiter wells. Chemical and physical characterisation by contact angle, ToF-SIMS, XPS and STM10.1016/S0927-7757(00)00497-0 ↗
20. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis10.1161/01.RES.73.6.1000 ↗
21. Smoothelin is an indicator of reversible phenotype modulation of smooth muscle cells in balloon-injured rat carotid arteries10.1007/s395-002-8382-z ↗
22. Cultured porcine coronary artery smooth muscle cells. A new model with advanced differentiation10.1161/01.RES.85.1.99 ↗
23. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells10.1083/jcb.134.2.401 ↗
24. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis10.1161/01.RES.75.5.803 ↗
25. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype10.1161/01.ATV.17.4.665 ↗
26. Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells10.1006/excr.1997.3525 ↗
27. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching10.1016/S0002-9440(10)63847-3 ↗
28. l-Ascorbic acid stimulates expression of smooth muscle-specific markers in smooth muscle cells both in vitro and in vivo10.1097/00005344-200312000-00008 ↗
29. Decrease in maximal force generation in the neonatal mouse bladder corresponds to shift in myosin heavy chain isoform composition10.1097/01.ju.0000092554.83715.8f ↗
30. Developmental aspects of bladder contractile function: sensitivity to extracellular calcium10.1159/000138829 ↗
31. Developmental aspects of bladder contractile function: evidence for an intracellular calcium pool10.1016/S0022-5347(17)35564-7 ↗
32. Developmental aspects of excitation contraction coupling of rabbit bladder smooth muscle10.1016/S0022-5347(17)32679-4 ↗
33. Smooth muscle myosin heavy chain isoforms are developmentally regulated in male fetal and neonatal sheep10.1203/00006450-199511000-00011 ↗
34. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow10.1016/j.yexcr.2004.11.011 ↗
35. Myofibroblast induction with transforming growth factor-beta1 and -beta3 in cutaneous fetal excisional wounds10.1016/S0022-3468(00)90007-1 ↗
36. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction10.1007/BF02147594 ↗
37. Transforming growth factor-beta 1 specifically induce proteins involved in the myofibroblast contractile apparatus10.1074/mcp.M300108-MCP200 ↗
38. Myofibroblasts and mechano-regulation of connective tissue remodelling10.1038/nrm809 ↗